Hormone Health: Invest Early for Lifetime Options #shorts

In this short interview, McCall McPherson and Speaker B discuss the massive scale of menopause in the United States—about 6,000 women enter menopause each day—and the implication that women will spend nearly half of their lives in this stage. They emphasize that hormone decline and related issues often begin much earlier than traditionally recognized, appearing in the 30s, 40s, and even the 20s, especially when compounded by thyroid problems, which they note are interrelated with hormonal health. The conversation highlights a shifting narrative around hormone replacement therapy (HRT), moving from a historically negative perception to a more balanced, hopeful view that supports early intervention. They also point out that younger audiences are increasingly engaged, with a third of recent event attendees under 30, suggesting a growing willingness among younger women to listen to their bodies and take proactive health measures. The overarching message is that investing in health early—addressing hormonal and thyroid health across life stages—expands the range of options and improves quality of life later, offering hope for a better menopausal experience for future generations.










